 | Up a level |
Curigliano, G.; Cardinale, D.; Suter, T.; Plataniotis, G.; De Azambuja, E.; Sandri, M. T.; Criscitiello, C.; Goldhirsch, A.; Cipolla, C.; Roila, F. (2012). Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Annals of oncology, 23(suppl 7), vii155-vii166. Oxford University Press 10.1093/annonc/mds293
Lenihan, D.; Suter, T.; Brammer, M.; Neate, C.; Ross, G.; Baselga, J. (2012). Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab. Annals of oncology, 23(3), pp. 791-800. Oxford University Press 10.1093/annonc/mdr294
Homazava, Nadzeya; Suter, T.; Schmutz, P.; Toggweiler, S.; Grimberg, A.; Krähenbühl, Urs; Ulrich, A. (2009). Online hyphenation of potentiostat to a microflow-capillary FI-ICP-MS for simultaneous in situ electrochemical, time and element resolved characterization of local corrosion processes-an application for Zr-bulk metallic glass. Journal of analytical atomic spectrometry, 24(9), pp. 1161-1169. London: Royal Society of Chemistry 10.1039/b901077g
Rayson, D.; Richel, D.; Chia, S.; Jackisch, C.; Van Der Vegt, S.; Suter, T. (2008). Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies. Annals of oncology, 19(9), pp. 1530-1539. Oxford University Press 10.1093/annonc/mdn292
